Involvement of the serotonergic system in the control of impulsivity in Tourette disorder : ARITEP - 69HCL22_0683

Hospices Civils De Lyon0 个研究点目标入组 20 人开始时间: 2023年7月5日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Male or Female, Diagnosed with a Tourette Disorder following the DSM-5, Age between 18-65 years, Member of a social security scheme in France, Freely-given informed consent to participate to this study (written form), With a current treatment by aripiprazole already scheduled, With Tics compatible with TEP/fMRI exams, Having (for women only) effective contraception throughout participation in the study.

•Male or Female, A serious not controlled psychiatric comorbidity, A serious, evolving or debilitating pathology with a potential influence on the study, Drug-taking with serotonergic effects (e.g., amphetamine, cocaine, MDMA, SSRIs, mianserin), Contraindication for fMRI and PET (e.g., pacemaker, ferromagnetic implant, claustrophobia), Women breastfeeding, Protected or restricted person (administratively or in judicial terms), Participants to another study with radiations or radiotracers since less of one year, participants to a concomitant study, Do not speak french

发起方